View Item 

Show simple item record

Transforming Growth Factor Beta-Induced Connective Tissue Growth Factor and Chronic Allograft Rejection †

dc.contributor.authorCsencsits, Keri L.en_US
dc.contributor.authorWood, S. C.en_US
dc.contributor.authorLu, G.en_US
dc.contributor.authorFaust, Susan Marieen_US
dc.contributor.authorBrigstock, D.en_US
dc.contributor.authorEichwald, Ernst J.en_US
dc.contributor.authorOrosz, C. G.en_US
dc.contributor.authorBishop, D. Keithen_US
dc.date.accessioned2010-06-01T20:03:54Z
dc.date.available2010-06-01T20:03:54Z
dc.date.issued2006-05en_US
dc.identifier.citationCsencsits, K.; Wood, S. C.; Lu, G.; Faust, S. M.; Brigstock, D.; Eichwald, E. J.; Orosz, C. G.; Bishop, D. K. (2006). "Transforming Growth Factor Beta-Induced Connective Tissue Growth Factor and Chronic Allograft Rejection † ." American Journal of Transplantation 6(5p1): 959-966. <http://hdl.handle.net/2027.42/73191>en_US
dc.identifier.issn1600-6135en_US
dc.identifier.issn1600-6143en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/73191
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16611331&dopt=citationen_US
dc.format.extent1006475 bytes
dc.format.extent3109 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherBlackwell Publishing Ltden_US
dc.rights2006 The American Society of Transplantation and the American Society of Transplant Surgeonsen_US
dc.subject.otherChronic Rejectionen_US
dc.subject.otherConnective Tissue Growth Factoren_US
dc.subject.otherFibrosisen_US
dc.subject.otherTransforming Growth Factor Betaen_US
dc.titleTransforming Growth Factor Beta-Induced Connective Tissue Growth Factor and Chronic Allograft Rejection †en_US
dc.typeArticleen_US
dc.subject.hlbsecondlevelMedicine (General)en_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumMicrobiology and Immunology, University of Michigan School of Medicine, Ann Arbor, MI 48109en_US
dc.contributor.affiliationotherFrom the Section of General Surgery, Department of Surgeryen_US
dc.contributor.affiliationotherDepartments of Human Geneticsen_US
dc.contributor.affiliationotherDepartment of Pathology, University of Utah School of Medicine, Salt Lake City, UT 84132en_US
dc.contributor.affiliationotherCenter for Cell and Vascular Biology, Children's Research Instituteen_US
dc.contributor.affiliationotherDivision of Transplantation, Department of Surgery, Ohio State University, Columbus, OH 43210en_US
dc.identifier.pmid16611331en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/73191/1/j.1600-6143.2006.01292.x.pdf
dc.identifier.doi10.1111/j.1600-6143.2006.01292.xen_US
dc.identifier.sourceAmerican Journal of Transplantationen_US
dc.identifier.citedreferenceHÄyry P, Isoniemi H, Yilmaz S et al. Chronic allograft rejection. Immunol Rev 1993; 134: 33 – 81.en_US
dc.identifier.citedreferenceLibby P, Pober JS. Chronic rejection. Immunity 2001; 14: 387 – 397.en_US
dc.identifier.citedreferenceOrosz CG, Pelletier RP. Chronic remodeling pathology in grafts. Curr Opin Immunol 1997; 9 ( 5 ): 676 – 680.en_US
dc.identifier.citedreferenceWeis M, von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 1997; 96: 2069 – 2077.en_US
dc.identifier.citedreferenceWaaga AM, Gasser M, Laskowski I, Tilney NL. Mechanisms of chronic rejection. Curr Opin Immunol 2000; 12: 517 – 521.en_US
dc.identifier.citedreferenceTullius SG, Tilney NL. Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995; 59: 313 – 318.en_US
dc.identifier.citedreferenceBorder WA, Ruoslahti E. Transforming growth factor-beta in disease: The dark side of tissue repair. J Clin Invest 1992; 90: 1 – 7.en_US
dc.identifier.citedreferenceFranklin TJ. Therapeutic approaches to organ fibrosis. Int J Biochem Cell Biol 1997; 29: 79 – 89.en_US
dc.identifier.citedreferenceWahl SM. Transforming growth factor Β: The good, the bad, and the ugly. J Exp Med 1994; 180: 1587 – 1590.en_US
dc.identifier.citedreferenceTabibzadeh S. Homeostasis of extracellular matrix by TGF-Β and lefty. Front Biosci 2002; 7: d1231 – 1246.en_US
dc.identifier.citedreferenceJain S, Furness PN, Nicholson ML. The role of transforming growth factor beta in chronic renal allograft nephropathy. Transplantation 2000; 69: 1759 – 1766.en_US
dc.identifier.citedreferenceLetterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16: 137 – 161.en_US
dc.identifier.citedreferenceBrattain MG, Markowitz SD, Willson JK. The type II transforming growth factor-beta receptor as a tumor-suppressor gene. Curr Opin Oncol 1996; 8: 49 – 53.en_US
dc.identifier.citedreferenceGupta S, Clarkson MR, Duggan J, Brady HR. Connective tissue growth factor: Potential role in glomerulosclerosis and tubulointerstitial fibrosis. Kidney Int 2000; 58: 1389 – 1399.en_US
dc.identifier.citedreferenceLeask A, Abraham DJ. The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol 2003; 81: 355 – 363.en_US
dc.identifier.citedreferenceGrotendorst GR, Okochi H, Hayashi N. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ 1996; 7: 469 – 480.en_US
dc.identifier.citedreferenceFrazier K, Williams S, Kothapalli D, Klapper H, Grotendorst GR. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor. J Invest Dermatol 1996; 107: 404 – 411.en_US
dc.identifier.citedreferenceIgarashi A, Nashiro K, Kikuchi K et al. Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders. J Invest Dermatol 1996; 106: 729 – 733.en_US
dc.identifier.citedreferenceDammeier J, Brauchle M, Falk W, Grotendorst GR, Werner S. Connective tissue growth factor: A novel regulator of mucosal repair and fibrosis in inflammatory bowel disease? Int J Biochem Cell Biol 1998; 30: 909 – 922.en_US
dc.identifier.citedreferencedi Mola FF, Friess H, Martignoni ME et al. Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999; 230: 63 – 71.en_US
dc.identifier.citedreferenceShi-wen X, Pennington D, Holmes A et al. Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis. Exp Cell Res 2000; 259: 213 – 224.en_US
dc.identifier.citedreferenceParadis V, Dargere D, Vidaud M et al. Expression of connective tissue growth factor in experimental rat and human liver fibrosis. Hepatology 1999; 30: 968 – 976.en_US
dc.identifier.citedreferenceChen MM, Lam A, Abraham JA, Schreiner GF, Joly AH. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis. J Mol Cell Cardiol 2000; 32: 1805 – 1819.en_US
dc.identifier.citedreferenceUzel MI, Kantarci A, Hong HH et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001; 72: 921 – 931.en_US
dc.identifier.citedreferenceWang S, Denichilo M, Brubaker C, Hirschberg R. Connective tissue growth factor in tubulointerstitial injury of diabetic nephropathy. Kidney Int 2001; 60: 96 – 105.en_US
dc.identifier.citedreferenceLeask A, Holmes A, Abraham DJ. Connective tissue growth factor: A new and important player in the pathogenesis of fibrosis. Curr Rheumatol Rep 2002; 4: 136 – 142.en_US
dc.identifier.citedreferenceRazzaque MS, Foster CS, Ahmed AR. Role of connective tissue growth factor in the pathogenesis of conjunctival scarring in ocular cicatricial pemphigoid. Invest Ophthalmol Vis Sci 2003; 44: 1998 – 2003.en_US
dc.identifier.citedreferenceCorry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343 – 350.en_US
dc.identifier.citedreferencePiccotti JR, Li K, Chan SY, Eichwald EJ, Bishop DK. Cytokine regulation of chronic cardiac allograft rejection: Evidence against a role for Th1 in the disease process. Transplantation 1999; 67: 1548 – 1555.en_US
dc.identifier.citedreferenceBishop DK, Shelby J, Eichwald EJ. Mobilization of T lymphocytes following cardiac transplantation: Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection. Transplantation 1992; 53: 849 – 857.en_US
dc.identifier.citedreferenceBishop DK, Chan Wood S, Eichwald EJ, Orosz CG. Immunobiology of allograft rejection in the absence of IFN-gamma: CD8+ effector cells develop independently of CD4+ cells and CD40-CD40 ligand interactions. J Immunol 2001; 166: 3248 – 3255.en_US
dc.identifier.citedreferenceNathan MJ, Yin D, Eichwald EJ, Bishop DK. The immunobiology of inductive anti-CD40L therapy in transplantation: Allograft acceptance is not dependent upon the deletion of graft-reactive T cells. Am J Transplant 2002; 2: 323 – 332.en_US
dc.identifier.citedreferenceChan SY, Li K, Piccotti JR et al. Tissue-specific consequences of the anti-adenoviral immune response: Implications for cardiac transplants. Nat Med 1999; 5: 1143 – 1149.en_US
dc.identifier.citedreferenceChan SY, Goodman RE, Szmuszkovicz JR, Roessler B, Eichwald EJ, Bishop DK. DNA-liposome versus adenoviral mediated gene transfer of transforming growth factor beta1 in vascularized cardiac allografts: Differential sensitivity of CD4+ and CD8+ T cells to transforming growth factor beta1. Transplantation 2000; 70: 1292 – 1301.en_US
dc.identifier.citedreferenceSteffen CL, Ball-Mirth DK, Harding PA, Bhattacharyya N, Pillai S, Brigstock DR. Characterization of cell-associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblast cells in vitro. Growth Factors 1998; 15: 199 – 213.en_US
dc.identifier.citedreferenceMori T, Kawara S, Shinozaki M et al. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol 1999; 181: 153 – 159.en_US
dc.identifier.citedreferenceChambers RC, Leoni P, Blanc-Brude OP, Wembridge DE, Laurent GJ. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 2000; 275: 35584 – 35591.en_US
dc.identifier.citedreferenceHowell DC, Goldsack NR, Marshall RP et al. Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mRNA levels in bleomycin-induced pulmonary fibrosis. Am J Pathol 2001; 159: 1383 – 1395.en_US
dc.identifier.citedreferenceKondo S, Kubota S, Shimo T et al. Connective tissue growth factor increased by hypoxia may initiate angiogenesis in collaboration with matrix metalloproteinases. Carcinogenesis 2002; 23: 769 – 776.en_US
dc.identifier.citedreferenceAbraham DJ, Shiwen X, Black CM, Sa S, Xu Y, Leask A. Tumor necrosis factor alpha suppresses the induction of connective tissue growth factor by transforming growth factor-Β in normal and scleroderma fibroblasts. J Biol Chem 2000; 275: 15220 – 15225.en_US
dc.identifier.citedreferenceRishikof DC, Ricupero DA, Kuang PP, Liu H, Goldstein RH. Interleukin-4 regulates connective tissue growth factor expression in human lung fibroblasts. J Cell Biochem 2002; 85: 496 – 504.en_US
dc.identifier.citedreferenceRicupero DA, Rishikof DC, Kuang PP, Poliks CF, Goldstein RH. Regulation of connective tissue growth factor expression by prostaglandin E 2. Am J Physiol 1999; 277: L1165 – 1171.en_US
dc.identifier.citedreferenceStratton R, Shiwen X, Martini G et al. Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients. J Clin Invest 2001; 108: 241 – 250.en_US
dc.identifier.citedreferenceBlom IE, Goldschmeding R, Leask A. Gene regulation of connective tissue growth factor: New targets for antifibrotic therapy? Matrix Biol 2002; 21: 473 – 482.en_US
dc.identifier.citedreferenceWorkalemahu G, Foerster M, Kroegel C, Braun RK. Human Γ/Δ-T lymphocytes express and synthesize connective tissue growth factor: Effect of IL-15 and TGF-Β 1 and comparison with Α/Β-T lymphocytes. J Immunol 2003; 170: 153 – 157.en_US
dc.identifier.citedreferenceUehara S, Chase CM, Kitchens WH et al. NK cells can trigger allograft vasculopathy: The role of hybrid resistance in solid organ allografts. J Immunol 2005; 175: 3424 – 3430.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
j.1600-6143.2006.01292.x.pdf
Size:
982.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.